Poultry Healthcare Market Report 2025

This Poultry Healthcare report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The poultry healthcare market size has grown rapidly in recent years. It will grow from $8.44 billion in 2024 to $9.31 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to disease outbreaks, increasing poultry production, globalization of poultry trade, regulatory compliance.

The poultry healthcare market size is expected to see rapid growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to rising global poultry consumption, focus on preventive healthcare, environmental concerns, integration of digital technologies, consumer awareness and demand. Major trends in the forecast period include technological integration, biosecurity measures, customized nutrition programs, global collaboration for disease surveillance, digital health records, market consolidation.

The rising incidence of disease outbreaks in poultry is anticipated to drive the growth of the poultry healthcare market. According to the United States Department of Agriculture (Animal and Plant Health Inspection Service), a US-based federal agency, the highly pathogenic avian influenza (HPAI) outbreak during FY (2022-2023) represents the largest and longest HPAI outbreak in U.S. history. The first case of HPAI in this outbreak was detected in February 2022. By August 2023, the National Veterinary Services Laboratory (NVSL) had confirmed 839 cases, impacting nearly 58.8 million birds. Therefore, the increasing prevalence of disease outbreaks is fueling the growth of the poultry healthcare market.

The growth of the poultry healthcare market is further anticipated to be fueled by the increasing consumption of poultry. Poultry, encompassing birds like chickens, turkeys, ducks, geese, and quail, is bred for meat and egg production. With a surge in the demand for poultry products, larger flocks are raised, resulting in higher disease risks due to crowded conditions. Prioritizing poultry healthcare becomes crucial to effectively prevent, control, and manage diseases. According to the USDA Economic Research Service in June 2023, the poultry sector witnessed total sales of $76. 9 billion, marking a substantial 67% increase compared to 2021. Significant increases were observed in broiler sales (60%), turkey sales (21%), and egg sales (122%) compared to 2021. Hence, the growing consumption of poultry is expected to drive the growth of the poultry healthcare market.

Major companies in the poultry healthcare market are developing advanced vaccines, such as the INNOVAX-ILT-IBD vaccine, to enhance protection against various diseases, improve flock health, and boost poultry production efficiency. For example, in June 2023, MSD Animal Health, a US-based company in the Veterinary Pharmaceuticals and Animal Health sector, launched the INNOVAX-ILT-IBD vaccine. This innovative vaccine is designed to protect poultry from three major diseases: infectious laryngotracheitis (ILT), infectious bursal disease (IBD), and Marek's disease (MD), all with a single dose. This advancement represents a significant progress in poultry healthcare, offering comprehensive protection against multiple viral threats.

Major companies in the poultry diagnostics market are creating Rapid Robenidine Test Reagents to improve the efficiency and accuracy of diagnosing and monitoring poultry health, particularly in detecting robenidine, an anticoccidial agent used to prevent coccidiosis in poultry. Robenidine Test Reagents are specialized diagnostic tools designed to identify robenidine residues in poultry meat and organs. These reagents are crucial for ensuring food safety and regulatory compliance concerning the use of robenidine, an antibiotic frequently used in veterinary medicine for treating coccidiosis in poultry. For example, in October 2024, Creative Diagnostics, a US-based company, introduced Rapid Robenidine Test Reagents for analyzing anticoccidial residues. These reagents are intended to quickly and accurately detect the presence of robenidine, ensuring compliance with safety and quality standards in poultry and other samples.

In July 2022, Wilbur-Ellis Nutrition, a US-based company offering products and solutions for the animal nutrition and feed industries, acquired F. L. Emmert for an undisclosed amount. This strategic acquisition aligns with Wilbur-Ellis Nutrition's priorities and enhances its core businesses, covering pet, livestock, and aquaculture solutions. F. L. Emmert, a US-based company, specializes in providing high-performance ingredients for both pet food and livestock feeds.

Major companies operating in the poultry healthcare market include Ceva Polchem Pvt. Ltd., Zoetis Inc., Venky's Ltd., Phibro Animal Health Corporation, Merck & Co Inc., C. H. Boehringer Sohn AG & Co. KG, Hester Biosciences Limited, Romvac Company S. A., Bayer AG, Indovax Pvt. Ltd., Affini Technology Limited, Bimeda Inc., IndexxLaboratories Inc., BioChek B. V., BioinGentech, MEGACOR Handel mit Medizintechnik u Diagnostika GmbH, Thermo Fisher Scientific Inc., Provet Pharma Private Limited, Anitox Corp., Aviagen Inc., Cobb-Vantress Inc., Hendrix Genetics BV, Hubbard LLC, Hy-Line International, Novogen, Lohmann Tierzucht, Romer Labs Pte Ltd.

North America was the largest region in the poultry healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the poultry healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the poultry healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Poultry healthcare encompasses services that provide healthcare solutions for domesticated birds such as chickens, turkeys, ducks, geese, quails, and others. These services involve managing various aspects of poultry health, including the elimination of sick birds, timely vaccinations, and the overall management of healthcare resources. Poultry management practices, such as ensuring cleanliness, proper feeding and feed supply, and appropriate housing, are also integral components of poultry healthcare.

The poultry healthcare market covered in this report is segmented by product into vaccines, parasiticides, anti-infectives, and medical feed additives. Vaccines play a crucial role in protecting farm animals by preventing or reducing the incidence of diseases, thereby lowering the risk of disease spread. Parasiticides target infectious parasites by either destroying them or inhibiting their growth. Anti-infectives, including antibacterials, antivirals, and antifungals, are medications designed to prevent or treat infections in livestock. Medical feed additives refer to extra nutrients or drugs added to livestock feed. The market is further divided into tests, which include ELISA, PCR, molecular diagnostic tests, and laboratory tests. In terms of application, the market is segmented into farm-based and house-based practices.

The poultry healthcare research report is one of a series of new reports that provides poultry healthcare statistics, including global poultry healthcare industry size, regional shares, competitors with poultry healthcare market share, detailed poultry healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the poultry healthcare industry. This poultry healthcare research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The poultry healthcare market includes revenues earned by entities by enhancing meat and egg productivity and avoiding rickets, rickets, and lameness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.